Department of Health and Human Services (hhs) April 2011 – Federal Register Recent Federal Regulation Documents

CERHR is evaluating the scientific evidence regarding the potential developmental effects of cancer chemotherapy during pregnancy. CERHR invites the submission of information about ongoing studies or upcoming publications on the pregnancy outcomes and long- term health of offspring exposed to cancer chemotherapy agents during pregnancy and associated topics that might be considered for inclusion in the evaluation. CERHR also invites the nomination of scientific experts to potentially serve as technical advisors in conducting the evaluation or as members of an ad hoc expert panel to be convened to peer review the draft Monograph on Cancer Chemotherapy during Pregnancy (see SUPPLEMENTARY INFORMATION). The peer review meeting is tentatively scheduled for August 29-30, 2011 at the NIEHS. When set, the date and location of the meeting will be announced in the Federal Register and posted on the CERHR Website (https://cerhr.niehs.nih.gov). The peer review meeting will be open to the public with time scheduled for oral public comment.